FibroBiologics, Inc.
41 SEC EDGAR filings indexed (CIK 0001958777) across 14 form types.
Filing profile
FibroBiologics, Inc. (FBLG) has 41 SEC filings indexed on SecFilingDex, across 14 form types, from November 20, 2025 to August 24, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).
Its most frequent disclosure is the 8-K (Material event) with 8 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 41 of these filings were disclosed in the twelve months to August 24, 2026. 2 of the 41 are amendments (a corrected or updated version of an earlier filing).
Disclosure mix
- 88-KMaterial event · event-driven
- 8Form 4Insider transaction · within 2 business days of transaction
- 5424B5Prospectus supplement · event-driven
- 4DEF 14AProxy statement · annual (pre-meeting)
- 3PRE 14ASEC filing
- 210-QQuarterly report · quarterly
- 2424B3Updated prospectus · event-driven
- 2DEFA14ASEC filing
- 2S-1IPO registration · event-driven (pre-ipo)
- 1Form 3Initial insider ownership · within 10 days of becoming an insider
- 18-K/AMaterial event · event-driven
- 1424B4Final prospectus · event-driven
- 110-K/AAnnual report · annual
- 110-KAnnual report · annual
Profile derived from 41 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
- 8-KMaterial event · period of report Aug 20, 2026Filed · 0001193125-26-362027
- DEF 14AProxy statement · period of report Sep 17, 2026Filed · 0001193125-26-326818
- 10-QQuarterly report · period of report Jun 30, 2026Filed · 0001193125-26-328454
- 8-KMaterial event · period of report Jul 22, 2026Filed · 0001193125-26-316067
- PRE 14ASEC filing · period of report Sep 17, 2026Filed · 0001193125-26-307822
- 424B3Updated prospectusFiled · 0001193125-26-306114
- Form 3Initial insider ownership · period of report Jul 8, 2026Filed · 0001493152-26-033509
- 8-KMaterial event · period of report Jul 2, 2026Filed · 0001193125-26-299290
- 8-KMaterial event · period of report Jun 25, 2026Filed · 0001193125-26-288468
- 8-KMaterial event · period of report Jun 22, 2026Filed · 0001193125-26-279778
- Form 4Insider transaction · period of report Jun 23, 2026Filed · 0001493152-26-029848
- Form 4Insider transaction · period of report Jun 23, 2026Filed · 0001493152-26-029849
- Form 4Insider transaction · period of report Jun 23, 2026Filed · 0001493152-26-029850
- Form 4Insider transaction · period of report Jun 23, 2026Filed · 0001493152-26-029851
- 424B5Prospectus supplementFiled · 0001193125-26-206852
- 8-KMaterial event · period of report May 5, 2026Filed · 0001193125-26-207530
- DEF 14AProxy statement · period of report May 5, 2026Filed · 0001193125-26-205032
- DEFA14ASEC filingFiled · 0001193125-26-205035
- 8-KMaterial event · period of report May 4, 2026Filed · 0001193125-26-205044
- Form 4Insider transaction · period of report May 4, 2026Filed · 0001493152-26-021172
- Form 4Insider transaction · period of report May 4, 2026Filed · 0001493152-26-021173
- Form 4Insider transaction · period of report May 4, 2026Filed · 0001493152-26-021174
- Form 4Insider transaction · period of report May 4, 2026Filed · 0001493152-26-021175
- 8-KMaterial event · period of report May 1, 2026Filed · 0001193125-26-201376
- 424B5Prospectus supplementFiled · 0001193125-26-201390
- 10-QQuarterly reportFiled · 0001193125-26-197858
- PRE 14ASEC filing · period of report Apr 22, 2026Filed · 0001193125-26-170595
- 8-K/AMaterial event · period of report Apr 3, 2026Filed · 0001193125-26-149865
- 424B4Final prospectusFiled · 0001193125-26-137949
- S-1IPO registrationFiled · 0001493152-26-013274
- 10-K/AAnnual report · period of report Dec 31, 2025Filed · 0001193125-26-106216
- 10-KAnnual report · period of report Dec 31, 2025Filed · 0001193125-26-066965
- 424B3Updated prospectusFiled · 0001493152-25-029628
- DEF 14AProxy statement · period of report Feb 20, 2026Filed · 0001193125-25-332248
- DEFA14ASEC filingFiled · 0001193125-25-332790
- S-1IPO registrationFiled · 0001493152-25-029010
- DEF 14AProxy statement · period of report Dec 18, 2025Filed · 0001193125-25-323667
- PRE 14ASEC filing · period of report Dec 18, 2025Filed · 0001193125-25-323907
- 424B5Prospectus supplementFiled · 0001193125-25-319435
- 424B5Prospectus supplementFiled · 0001193125-25-294631
- 424B5Prospectus supplementFiled · 0001193125-25-288465
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.